BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30172799)

  • 1. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
    Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
    Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
    Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
    J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
    [No Abstract]   [Full Text] [Related]  

  • 3. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening.
    O'Connor M; O'Leary E; Waller J; Gallagher P; Martin CM; O'Leary JJ; Sharp L;
    Prev Med; 2018 Oct; 115():90-96. PubMed ID: 30144488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review.
    Nothacker J; Nury E; Roebl Mathieu M; Raatz H; Meerpohl JJ; Schmucker C
    BMJ Sex Reprod Health; 2022 Oct; 48(4):295-306. PubMed ID: 36223918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV testing and vaccination in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
    Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
    Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
    Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study.
    Griffin-Mathieu G; Haward B; Tatar O; Zhu P; Perez S; Shapiro GK; McBride E; Thompson EL; Smith LW; Lofters AK; Daley EM; Guichon JR; Waller J; Steben M; Decker KM; Mayrand MH; Brotherton JML; Ogilvie GS; Zimet GD; Norris T; Rosberger Z
    JMIR Res Protoc; 2022 Jun; 11(6):e38917. PubMed ID: 35708742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Wong ELY; Cheung AWL; Huang F; Chor JSY
    Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in Cameroon.
    Sossauer G; Zbinden M; Tebeu PM; Fosso GK; Untiet S; Vassilakos P; Petignat P
    PLoS One; 2014; 9(10):e109788. PubMed ID: 25333793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.
    Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A
    J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominican Provider Attitudes Towards HPV Testing for Cervical Cancer Screening and, Current Challenges to Cervical Cancer Prevention in the Dominican Republic: a Mixed Methods Study.
    Liebermann E; Van Devanter N; Frías Gúzman N; Hammer MJ; Ompad D
    J Cancer Educ; 2021 Dec; 36(6):1170-1185. PubMed ID: 32307667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent changes in cervical cancer screening guidelines: U.S. women's willingness for HPV testing instead of Pap testing.
    Thompson EL; Galvin AM; Daley EM; Tatar O; Zimet GD; Rosberger Z
    Prev Med; 2020 Jan; 130():105928. PubMed ID: 31756351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.